MetLife Investment Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Hold |
|
|||||
|
2025
Q1 | $761K | Sell |
|
|||||
|
2024
Q4 | $1.13M | Buy |
|
|||||
|
2024
Q3 | $1.23M | Hold |
|
|||||
|
2024
Q2 | $773K | Buy |
|
|||||
|
2024
Q1 | $834K | Buy |
|
|||||
|
2023
Q4 | $508K | Hold |
|
|||||
|
2023
Q3 | $278K | Hold |
|
|||||
|
2023
Q2 | $459K | Hold |
|
|||||
|
2023
Q1 | $592K | Hold |
|
|||||
|
2022
Q4 | $498K | Sell |
|
|||||
|
2022
Q3 | $484K | Buy |
|
|||||
|
2022
Q2 | $379K | Hold |
|
|||||
|
2022
Q1 | $814K | Buy |
|
|||||
|
2021
Q4 | $778K | Hold |
|
|||||
|
2021
Q3 | $719K | Buy |
|
|||||
|
2021
Q2 | $542K | Buy |
|
|||||
|
2021
Q1 | $177K | Hold |
|
|||||
|
2020
Q4 | $282K | Buy |
|